BIMZELX
BIMZELX
Approved
DIN Number
02553619
Drug Class
Human
Market Date
Apr 7, 2025
Company
HC
UCB Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02553619
AIG Number0163399001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC21 BIMEKIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
BIMEKIZUMABActive
Strength: 320 MG / 2 ML
Monograph: BIMEKIZUMAB